Bio View (Israel) Today
| BIOV Stock | ILS 17.60 0.40 2.22% |
PerformanceFair
| Odds Of DistressLow
|
Bio View is trading at 17.60 as of the 11th of February 2026, a 2.22 percent decrease since the beginning of the trading day. The stock's open price was 18.0. Bio View has less than a 10 % chance of experiencing some financial distress in the next two years of operation and had a fair performance during the last 90 days. The performance scores are derived for the period starting the 13th of November 2025 and ending today, the 11th of February 2026. Click here to learn more.
BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. The company has 13.75 M outstanding shares. More on Bio View
Moving together with Bio Stock
Moving against Bio Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bio Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bio View's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bio View or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and Pres | Alan Schwebel |
| Business Concentration | Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Bio View (BIOV) is traded on Tel Aviv Stock Exchange in Israel and employs 35 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 53.86 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bio View's market, we take the total number of its shares issued and multiply it by Bio View's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bio View operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 13.75 M outstanding shares.
Bio View has accumulated about 17.67 M in cash with 3.25 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24.
Check Bio View Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Bio View is S53.86 Million. Bio View retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with substantial debt, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
Check Bio Ownership Details
Bio View Risk Profiles
Although Bio View's alpha and beta are two of the key measurements used to evaluate Bio View's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.81 | |||
| Semi Deviation | 2.96 | |||
| Standard Deviation | 3.87 | |||
| Variance | 14.94 |
Bio Stock Against Markets
Bio Stock Analysis Notes
About 52.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bio View last dividend was issued on the 22nd of March 2017. The entity had 10:1 split on the 24th of December 2023. BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel. For more info on Bio View please contact Alan Schwebel at 972 73 227 1025 or go to https://www.bioview.com.Bio View Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Bio View's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Bio View or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Bio Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 53.86 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bio View's market, we take the total number of its shares issued and multiply it by Bio View's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Bio Profitablity
Bio View's profitability indicators refer to fundamental financial ratios that showcase Bio View's ability to generate income relative to its revenue or operating costs. If, let's say, Bio View is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Bio View's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Bio View's profitability requires more research than a typical breakdown of Bio View's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. Technical Drivers
As of the 11th of February 2026, Bio View shows the Mean Deviation of 2.81, risk adjusted performance of 0.0375, and Downside Deviation of 3.57. Bio View technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Bio View Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bio View Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Bio View price patterns.
Bio View Outstanding Bonds
Bio View issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bio View uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bio bonds can be classified according to their maturity, which is the date when Bio View has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Bio View Predictive Daily Indicators
Bio View intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bio View stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 4390.56 | |||
| Daily Balance Of Power | (0.40) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 17.5 | |||
| Day Typical Price | 17.53 | |||
| Price Action Indicator | (0.10) | |||
| Period Momentum Indicator | (0.40) |
Bio View Forecast Models
Bio View's time-series forecasting models are one of many Bio View's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bio View's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in Bio View without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Other Information on Investing in Bio Stock
Bio View financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio View security.